Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $2.04 in the prior trading day, Phio Pharmaceuticals Corp (NASDAQ: PHIO) closed at $1.80, down -11.76%. In other words, the price has decreased by -$11.76 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
Our goal is to gain a better understanding of PHIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.65 and its Current Ratio is at 5.65. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 05, 2020, initiated with a Buy rating and assigned the stock a target price of $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 07 ’24 when Bitterman Robert J bought 1,000 shares for $0.74 per share. The transaction valued at 740 led to the insider holds 20,990 shares of the business.
Bitterman Robert J bought 1,000 shares of PHIO for $750 on Jun 06 ’24. The President & CEO now owns 19,990 shares after completing the transaction at $0.75 per share.
Stock Price History:
Over the past 52 weeks, PHIO has reached a high of $9.79, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 10.71%, while the 200-Day Moving Average is calculated to be -26.10%.
Shares Statistics:
A total of 4.78M shares are outstanding, with a floating share count of 4.75M. Insiders hold about 0.67% of the company’s shares, while institutions hold 5.68% stake in the company.
